VIVUS, Inc. Announces Presentation of Qnexa Data at the 2008 BIO International Convention

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--VIVUS, Inc (NASDAQ: VVUS) a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that, Peter Tam, senior vice president of Product and Corporate Development, is scheduled to present an overview of Qnexa, the company’s investigational product for the treatment of obesity and diabetes, during a panel discussion entitled “Confronting the Obesity Epidemic: The Skinny on Innovative New Treatments” at the 2008 BIO International Convention. The panel will take place on June 18 at 4:00 P.M. local time in room 30A of the San Diego Convention Center.